305 related articles for article (PubMed ID: 21943108)
1. A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.
Palmer GM; Tiran Z; Zhou Z; Capozzi ME; Park W; Coletta C; Pyriochou A; Kliger Y; Levy O; Borukhov I; Dewhirst MW; Rotman G; Penn JS; Papapetropoulos A
Br J Pharmacol; 2012 Mar; 165(6):1891-1903. PubMed ID: 21943108
[TBL] [Abstract][Full Text] [Related]
2. Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.
Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
Curr Eye Res; 2021 Oct; 46(10):1551-1558. PubMed ID: 33870816
[No Abstract] [Full Text] [Related]
3. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
[TBL] [Abstract][Full Text] [Related]
4. Novel Peptide NT/K-CRS Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization
Yao X; Chen C; Zhang J; Xu Y; Xiong S; Gu Q; Xu X; Suo Y
J Ocul Pharmacol Ther; 2021 Sep; 37(7):412-420. PubMed ID: 34252290
[No Abstract] [Full Text] [Related]
5. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
[No Abstract] [Full Text] [Related]
6. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
7. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
[TBL] [Abstract][Full Text] [Related]
8. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.
Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X
Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024
[TBL] [Abstract][Full Text] [Related]
9. β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models.
Dahham SS; Tabana Y; Asif M; Ahmed M; Babu D; Hassan LE; Ahamed MBK; Sandai D; Barakat K; Siraki A; Majid AMSA
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638895
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
11. Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model.
Tabana YM; Hassan LE; Ahamed MB; Dahham SS; Iqbal MA; Saeed MA; Khan MS; Sandai D; Majid AS; Oon CE; Majid AM
Microvasc Res; 2016 Sep; 107():17-33. PubMed ID: 27133199
[TBL] [Abstract][Full Text] [Related]
12. The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature.
Luo Y; Yin J; Fang R; Liu J; Wang L; Zhang H; Zhang M; Lei Z; Liang S; Cui W; Zhang Z; Wu K; Hui X
Eur J Pharmacol; 2021 Dec; 912():174574. PubMed ID: 34662566
[TBL] [Abstract][Full Text] [Related]
13. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
15. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic properties of a sulindac analogue.
Pyriochou A; Tsigkos S; Vassilakopoulos T; Cottin T; Zhou Z; Gourzoulidou E; Roussos C; Waldmann H; Giannis A; Papapetropoulos A
Br J Pharmacol; 2007 Dec; 152(8):1207-14. PubMed ID: 17965739
[TBL] [Abstract][Full Text] [Related]
17. Novel peptide derived from IGF-2 displays anti-angiogenic activity in vitro and inhibits retinal angiogenesis in a model of oxygen-induced retinopathy.
Zheng Y; Sun Q; Xu X; Wang W
Clin Exp Ophthalmol; 2020 Dec; 48(9):1261-1275. PubMed ID: 33026147
[TBL] [Abstract][Full Text] [Related]
18. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
19. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]